Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia
Clinical trial NCT03624270 · UNKNOWN
Trial details
- NCT number
- NCT03624270
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2023-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.